Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
29/04/2024

Archive: 29/04/2024

Nutritional interventions for moderate- to late-preterm infants show no effect

Routine nutrition interventions to support moderate- to late-preterm infants until full nutrition with mother's breast milk does not impact outcomes, according to a study published in the New England Journal of Medicine.

Apr 29, 2024

0

0

Home vision tests offer limited diagnostic accuracy for neovascular AMD

No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active neovascular age-related macular degeneration (nAMD), according to a study published online April 25 in ...

Apr 29, 2024

0

0

Polyamorous youth report facing stigma, heightened levels of depression

While increasingly visible among adults, polyamory also exists among adolescents, and as a new study indicates, so does the stigma that can come with it.

Apr 29, 2024

0

0

Stem cells improve memory, reduce inflammation in Alzheimer's mouse brains

When people think of Alzheimer's Disease and possible treatment, amyloid—and the accumulation of plaques that invade the cerebral cortex—is often brought up first. However, scientists are finding that Alzheimer's is influenced ...

Apr 29, 2024

0

1

Pathfinders for Autism helps people with autism, families navigate diagnosis

One of Rebecca Rienzi's favorite stories to tell about Pathfinders for Autism—the Baltimore County nonprofit where she has been executive director since 2010—happened at the National Aquarium in the Inner Harbor.

Apr 29, 2024

0

1

The path to a better tuberculosis vaccine runs through Montana

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.

Apr 29, 2024

0

1

Curbing the price of novel diabetes and obesity medications

For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for ...

Apr 29, 2024

0

0

Laws requiring doctors to report a dementia diagnosis to the DMV may backfire

Some states require that physicians report a diagnosis of dementia, including Alzheimer's disease, to the DMV. A new study suggests these mandates may have unintended consequences.

Apr 29, 2024

1

85

FDA brings lab tests under federal oversight in bid to improve accuracy and safety

Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.

Apr 29, 2024

0

0

Trial shows lower dose of mpox vaccine is safe, generates six-week antibody response equivalent to standard regimen

A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to findings presented ...

Apr 29, 2024

0

0

page 5 from 10

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us